We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

27 hedge funds and large institutions have $5.03M invested in Vaccinex, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

8% more funds holding

Funds holding: 25 → 27 (+2)

8% less capital invested

Capital invested by funds: $5.49M → $5.03M (-$459K)

31% less call options, than puts

Call options by funds: $25K | Put options by funds: $36K

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
4
Closed
3
Calls
$25K
Puts
$36K
Net Calls
-$11K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
+$537K
2
Millennium Management
Millennium Management
New York
+$147K
3
Simplex Trading
Simplex Trading
Illinois
+$54.4K
4
TSS
Two Sigma Securities
New York
+$46K
5
Goldman Sachs
Goldman Sachs
New York
+$27.3K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$299K
2
TI
Telemetry Investments
New York
-$61.8K
3
HF
HRT Financial
New York
-$21K
4
OC
Oppenheimer & Co
New York
-$19K
5
Citadel Advisors
Citadel Advisors
Florida
-$12K

VCNX Hedge Fund Activity: Q2 2022 in Review

27 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q2 2022, worth a combined $5.03M — down 8.4% from $5.49M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new VCNX positions and 3 closed out — a net gain of 2 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Worth Venture Partners, adding an estimated $537K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $299K sold.

  • 27 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q2 2022, up from 25 in Q1 2022.
  • Funds reported $5.03M of Vaccinex, Inc. Common Stock stock for Q2 2022, down 8.4% quarter-over-quarter.
  • 5 funds opened new Vaccinex, Inc. Common Stock positions in Q2 2022 and 3 closed out, a net change of +2 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q2 2022 was Worth Venture Partners, an estimated $537K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q2 2022 was Point72 Asset Management, an estimated $299K sold.

Based on aggregated 13F filings for Q2 2022.